Table 3.
Patterns of disease recurrence in patients with oesophageal cancer that achieved R0 resection after 2 vs. 3 courses of neoadjuvant chemotherapy (NAC).
| Recurrence site | 2 NAC courses (N = 86) | 3 NAC courses (N = 82) | P value |
|---|---|---|---|
| Overall number of recurrences | 25 (29.1%) | 20 (26.8%) | 0.493 |
| Locoregional | 9 (34.6%) | 7 (35.0%) | 0.978 |
| Distant | 16 (61.5%) | 13 (65.0%) | 0.809 |
| Lymph node | 6 (23.1%) | 5 (25.0%) | 0.880 |
| Liver | 4 (15.4%) | 1 (5.0%) | 0.243 |
| Lung | 4 (15.4%) | 5 (25.0%) | 0.417 |
| Bone | 4 (15.4%) | 3 (15.0%) | 0.971 |
| Brain | 0 (%) | 1 (5.0%) | 0.193 |
| Pleura | 2 (7.7%) | 0 (0%) | 0.125 |
| Others | 1 (3.9%) | 2 (10.0%) | 0.403 |